ÂÜÀòÂÒÂ×

Nicolas G. Sitchon, M.A., M.B.A. has served as Chairman of the board of directors and as the President and Chief Executive Officer since the founding in October 2010. From October 2008 to October 2010, Mr. Sitchon performed services in anticipation of incorporation of the company and related to the development of their lead product candidate, LorexysTM. From April 2006 to October 2008, Mr. Sitchon was Global Research & Development Controller at Bayer HealthCare Consumer Care, a division of Bayer AG. Prior to that time, Mr. Sitchon held positions in marketing, information technology, business intelligence and business planning in the cardiovascular and neuroscience franchises of the Pharmaceuticals division of Novartis Corporation. Mr. Sitchon received his M.A. in Medical Science from the Boston University School of Medicine and his M.B.A. from the Boston University School of Management. He completed his undergraduate studies at the University of California, Berkeley. Mr. Sitchon was selected to serve as a member of the Board of Directors because of his role in developing, and his extensive knowledge regarding, the product candidates; his experience as the executive officer; because of his proven ability to pursue the development of product candidates in an efficient manner using minimal capital; and because of his advanced degrees in science and business.